Nymox Pharmaceutical Corp
(NASDAQ : NYMX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.74%75.260.8%$473.31m
MDTMedtronic PLC
1.16%92.290.6%$467.57m
ISRGIntuitive Surgical, Inc.
2.32%548.502.4%$425.24m
TMOThermo Fisher Scientific Inc.
2.56%252.441.0%$395.89m
ALGNAlign Technology, Inc.
1.68%254.966.3%$378.26m
SYKStryker Corporation
0.67%186.791.3%$314.48m
BSXBoston Scientific Corporation
0.23%40.011.1%$294.43m
BDXBecton, Dickinson and Company
1.59%248.391.1%$270.36m
TFXTeleflex Incorporated
1.51%285.785.4%$247.14m
BAXBaxter International Inc.
1.38%73.441.7%$223.09m
EWEdwards Lifesciences Corporation
0.95%177.791.2%$215.36m
ABMDABIOMED, Inc.
1.19%362.063.3%$187.02m
WATWaters Corporation
1.39%234.713.5%$175.89m
ZBHZimmer Biomet Holdings, Inc.
0.94%123.641.7%$173.58m
DXCMDexCom, Inc.
0.45%148.498.5%$159.41m

Company Profile

Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.